Chan Henry Lik-Yuen, Tse Chi-Hang, Ng Eddie Yuen-Tok, Leung Kwong-Sak, Lee Kin-Hong, Tsui Stephen Kwok-Wing, Sung Joseph Jao-Yiu
Department of Medicine and Therapeutics and Institute of Digestive Diseases, 9/F Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong, Hong Kong.
J Clin Microbiol. 2006 Mar;44(3):681-7. doi: 10.1128/JCM.44.3.681-687.2006.
Hepatitis B virus (HBV) with T-1856 of the precore region is always associated with C-1858 (i.e., TCC at nucleotides 1856 to 1858), and it is reported only in genotype C HBV isolates. We aimed to investigate the phylogenetic, virological, and clinical characteristics of HBV isolates bearing TCC at nucleotides 1856 to 1858. We have previously reported on the presence of two major subgroups in genotype C HBV, namely, HBV genotype Cs (Southeast Asia) and HBV genotype Ce (Far East). We have designed a novel 5' nuclease technology based on the nucleotide polymorphism (C or A) at nucleotide 2733 to differentiate the two genotype C HBV subgroups. The mutations at the basal core promoter and precore regions were analyzed by direct sequencing. Among 214 genotype C HBV-infected patients, 31% had TCC, 37% had CCC, 3% had CTC, and 29% had CCT at nucleotides 1856 to 1858. All except one HBV strain with TCC at nucleotides 1856 to 1858 belonged to subgroup Cs, which has been reported only in Hong Kong; Guangzhou, China; and Vietnam. HBV with TCC at nucleotides 1856 to 1858 was associated with the G1898A mutation (64%). Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43). In summary, we report that HBV with TCC at nucleotides 1856 to 1858 of the precore region might represent a specific HBV strain associated with more aggressive liver disease than other genotype C HBV strains.
前核心区T-1856的乙型肝炎病毒(HBV)总是与C-1858相关联(即核苷酸1856至1858处为TCC),并且仅在C基因型HBV分离株中报道过。我们旨在研究核苷酸1856至1858处携带TCC的HBV分离株的系统发育、病毒学和临床特征。我们之前报道过C基因型HBV存在两个主要亚组,即HBV基因型Cs(东南亚)和HBV基因型Ce(远东)。我们基于核苷酸2733处的核苷酸多态性(C或A)设计了一种新型的5'核酸酶技术,以区分这两个C基因型HBV亚组。通过直接测序分析基础核心启动子和前核心区的突变。在214例C基因型HBV感染患者中,31%在核苷酸1856至1858处为TCC,37%为CCC,3%为CTC,29%为CCT。除了一株在核苷酸1856至1858处为TCC的HBV毒株外,所有其他毒株均属于Cs亚组,该亚组仅在香港、中国广州和越南有报道。核苷酸1856至1858处为TCC的HBV与G1898A突变相关(64%)。携带TCC的HBV感染者比携带CCC的HBV感染者有更多的肝硬化患者(18%对5%;P = 0.008),并且携带TCC的HBV感染者中HBeAg阳性的患者更多(58%对36%;P = 0.01),丙氨酸转氨酶水平中位数更高(65 IU/升对49 IU/升;P = 0.006);但携带TCC的HBV感染者和携带CCT的HBV感染者中肝硬化患者的比例相似(18%对13%;P = 0.43)。总之,我们报告前核心区核苷酸1856至1858处为TCC的HBV可能代表一种比其他C基因型HBV毒株更具侵袭性肝病相关的特定HBV毒株。